Stop using nowDrug recall · FDA · Published February 1, 2024
Insight TING Athlete's Foot Spray Recall: Benzene Chemical Contamination Hazard
Insight Pharmaceuticals recalls TING 1% Tolnaftate Athlete's Foot Spray due to benzene contamination. Affected lots expire 07/31/24 or 06/30/25. Stop using immediately to avoid chemical exposure.
“Insight TING Athlete's Foot Spray Recall: Benzene Chemical Contamination Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32840-insight-ting-athlete-s-foot-spray-recall-benzene-chemical-contamination. Based on FDA recall #D-0346-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0346-2024%22&limit=1).
The FDA announced on Feb. 1, 2024, that Insight Pharmaceuticals LLC is recalling TING 1% Tolnaftate Athlete's Foot Spray due to benzene contamination. The agency classified the Class I recall as voluntary.
The recall addresses the presence of benzene, a known carcinogen, in the antifungal spray liquid. The FDA classified this as a Class I hazard.
Context
GovInfoNow's records show Insight Pharmaceuticals LLC has 2 other recalls on record since 2023-12-21. On 2023-12-21, the company recalled Americaine benzocaine spray due to benzene contamination. Other recent recalls of similar products include Owen Biosciences Night Lotion Recall (2026-03-03), Sandra Lee MD Acne Spot Treatment Recall (2026-03-03), and Owen Biosciences Recalls Acne Lotion with Benzene Contamination (2026-03-03).
How to tell if you have this one
Check for TING 1% Tolnaftate Athlete's Foot Spray cans labeled with lot numbers 0H50545 (expiring 07/31/24) or 1G50645 (expiring 06/30/25).
Brand
Insight
Product
TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discard the recalled TING Athlete's Foot Spray cans to avoid exposure to benzene.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 27 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0346-2024 (February 1, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0346-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.